QOL for Malignancies

Phase-Based Estimates
1
Effectiveness
1
Safety
BC Cancer, Vancouver, Canada
QOL - Behavioral
Eligibility
18+
All Sexes
Eligible conditions
Malignancies

Study Summary

This study is evaluating whether a new treatment for rare cancers is effective and safe in the real world.

See full description

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether QOL will improve 1 primary outcome and 5 secondary outcomes in patients with Malignancies. Measurement will happen over the course of Baseline until progression up to 5 years.

Year 5
Overall survival from initiation of targeted therapy
Quality adjusted survival from initiation of targeted therapy
Quality of life (QoL) assessments using the EQ-5D every 8 weeks from initiation of targeted therapy
Year 5
Progression free survival (PFS) from initiation of targeted therapy
Response rate as defined by RECIST 1.1
Response rate as defined by physician assessed response

Trial Safety

Safety Estimate

1 of 3

Trial Design

2 Treatment Groups

Control
Targeted therapy

This trial requires 30 total participants across 2 different treatment groups

This trial involves 2 different treatments. QOL is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Targeted therapy
ControlNo treatment in the control group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CT imaging
2020
N/A
~1020
QOL
2001
N/A
~30

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline until death up to 5 years
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly baseline until death up to 5 years for reporting.

Closest Location

BC Cancer - Vancouver, Canada

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 7 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Subject age greater than or equal to 18 years at the time of signature of informed consent.
Subjects with an incurable malignancy who have been identified to have a rare cancer or rare molecular aberration who is currently receiving Health Canada approved targeted therapy that is not nationally funded
ECOG 0-2
Life expectancy of at least 12 weeks
Adequate hematologic and end organ function for drug treatment per the clinician's assessment
Asymptomatic or treated brain metastases permitted
Ability to give informed consent for the study procedures defined in this protocol.

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can malignancies be cured?

Add answer

If malignancies can be cured, then why is the word malignant? Even though some malignancies can be cured, other malignancies have no way of curing themselves. Malignancies are not born and are not cured, they are grown. Treating malignancies would have to happen all the way along. In other words, curing malignancies would have to start with stopping cancer growth, which would happen when a malignancy's main way of life is gone. Because cancer cells take over cells and tissues to maintain their life, curing cancer can be the hardest part of the treatment of any malignancy. [Power(https://www.fightingblindness.

Unverified Answer

What causes malignancies?

Add answer

Malignancies are probably caused by environmental mutagens that may contribute to carcinogenesis, particularly certain viruses, including human papillomavirus, as well as bacterial or fungal infection. These agents interact with environmental factors, like smoking and asbestos, or may trigger a new cascade of events in the colon crypts causing epithelial dysplasia. Genetic predisposition may play a role, particularly in patients who have lost a sibling or other family member to cancer. Thus, risk is probably better estimated in childhood than in older age when familial clustering becomes more evident.

Unverified Answer

How many people get malignancies a year in the United States?

Add answer

The U.S. Preventive Services Task Force found that more than 15 million Americans will be diagnosed with malignancies and be expected to die from them in 2040. Lung cancer will be the most common cause of cancer deaths. Lung cancer mortality can be reduced without waiting for the development of treatments that delay cancer in the early stages of tumor development.

Unverified Answer

What is malignancies?

Add answer

Cancer is a life-threatening disorder that can affect a person's physical appearance, behavior and can have devastating effects on health and quality of life. In 2011, cancer occurred to about 1.25 million of Canadians. Most types of cancer involve the colon, lung, breast, rectum and prostate and a small number involve the skin. In 2009, about 583 thousand people died of cancer, down from 636 thousand in 1990.

Unverified Answer

What are the signs of malignancies?

Add answer

Many signs and symptoms of malignancies are nonspecific. The presenting complaint may often be a vague indicator of other underlying causes. The clinical history and physical examination are important components of the initial screen for malignancies.

Unverified Answer

What are common treatments for malignancies?

Add answer

Many treatments are used for the common malignancies of lung, brain, pancreas, breast, and prostate. These include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and immunopharmacotherapy.\n

Unverified Answer

What are the common side effects of qol?

Add answer

Symptoms were similar to previous studies. They were more likely seen in men than women (P <.0001). Men had a higher frequency of headaches (36%, vs. 22% women, P =.032) and micturition/urinary symptoms (21%, vs. 20%, P =.027). Both groups had a similar rate of somnolence (30%, vs. 37%, P =.014). Overall, insomnia was not significantly more common in women (32 vs. 30%, P =.818) or men (20% vs. 17%, P =.062). Most side effects were mild to moderate in severity, except for pain/tenderness (P =.

Unverified Answer

What is the primary cause of malignancies?

Add answer

The most frequent neoplasms found were: (1) non-melanocytic tumors; (2) non-skin melanomas; (3) gastrointestinal and respiratory tract malignancies; (4) leukemias, lymphomas and other hematopoietic and lymphatic malignancies; while (5) other malignancies, including CNS, breast, gynecologic and prostate cancers were less frequent. This is important information to know when evaluating a patient with hematologic malignancies.

Unverified Answer

Who should consider clinical trials for malignancies?

Add answer

These patients can benefit from trials investigating therapeutic agents that are effective against malignant cancer cell proliferation and/or the development of resistance to anticancer drugs in these patients. However, the design of appropriate trials requires a precise assessment by clinical investigators of which patients are eligible for trials, which drugs may help patients, and the optimal duration and schedule of therapy.

Unverified Answer

Have there been other clinical trials involving qol?

Add answer

Because of ethical issues, we cannot do more trials comparing alternative treatments. However, we can do studies in which each group is evaluated individually, not as a whole, so that people's preferences play a bigger role.

Unverified Answer

What is qol?

Add answer

The WHO-QOL questionnaire is an essential tool of the assessment of patients' quality of everyday life. It is useful for assessing QoL of the patient, and for the healthcare professionals: doctors, nurses and therapists. The questionnaire may be useful for the patients and nurses, for the other patients and for the healthcare professionals and the relatives of the patients. It may also be useful for the physicians and for the other health professionals. Thus, the WHO-QOL questionnaire becomes a useful tool for the patients and their relatives and healthcare professionals. Therefore, it may be of interest to use the WHO-QOL questionnaire in clinical practice and research in all clinical areas: oncologic, cardiorespiratory, endocrinology, etc.

Unverified Answer

What does qol usually treat?

Add answer

QLC treatment is the only one for which it is possible to establish the true value of the patient's health status and QLC treatments. Patients who receive QOL treatment will receive the best treatment possible in the short term. The QOL treatment is particularly beneficial to women, who may be in a position to give their physicians an accurate summary of their health state and need for treatment on their own, for the first time. This knowledge is particularly useful for women who live alone and are responsible for the treatment of their grandchildren. Furthermore, the treatment of women's health, health and QOL requires the skills of all health professionals and the willingness of patients to accept the advice of health professionals in the management of women's life.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Malignancies by sharing your contact details with the study coordinator.